No shortage on file

PAPAVERINE HYDROCHLORIDE INJECTION USP

SANDOZ CANADA INCORPORATED

Quick answers

Is there a shortage of PAPAVERINE HYDROCHLORIDE INJECTION USP in Canada?

No. There is no current shortage of PAPAVERINE HYDROCHLORIDE INJECTION USP 65MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

DIN

00009881

Strength

65MG

Dosage Form

LIQUID

Route

SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR

Active Ingredient

PAPAVERINE HYDROCHLORIDE

See all PAPAVERINE HYDROCHLORIDE products →

Compare with another product →

Product Monograph

Product monograph is not available from Health Canada

View official Health Canada drug record ↗

Shortage History

2024-08-15

Shortage Avoided

Disruption of the manufacture of the drug.

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929